Advances in Adult Stem Cell Products and Technology for Cancer Treatment

Strategic Insights -

Researchers at Vitro Diagnostics, Inc., a leading biopharmaceutical company, have made significant breakthroughs in adult stem cell products and technology, with applications in cell-based therapy for cancer. The development of novel stem cell technology and products may lead to novel cell therapy for cancer, including treatment of currently untreatable cancer types. This breakthrough has significant implications for the prevention and treatment of cancer.

Key Takeaways:

  • Vitro Diagnostics, Inc. has made significant advances in adult stem cell products and technology, with applications in cell-based therapy for cancer.
  • Cancer stem cells are thought to generate cancerous tumors and resist conventional treatments, such as chemotherapy and radiation.
  • Research has shown that certain adult stem cells can selectively eradicate cancer stem cells, providing a novel approach to cancer treatment.
  • Vitro's proprietary stem cell technology and products are pending patent protection and are being pursued for commercialization as novel therapeutic products.
  • The company has commercialized various modified stem cell lines and related products to support cancer stem cell research, including methods to target the selective eradication of cancer stem cells.
  • These products and other tools for use in stem cell research are now commercially available through Vitro Biopharma.

Specific Applications and Initiatives:

  • Development of novel cell therapy for cancer, including treatment of glioblastoma tumors.
  • Use of adult stem cells to selectively eradicate cancer stem cells, providing novel cellular therapy.

Statistics:

  • Cancer stem cells are estimated to be responsible for 2-5% of all cancer cells, but are thought to be responsible for cancer recurrence and metastasis (Source: National Cancer Institute).
  • Glioblastoma tumors are a type of aggressive brain cancer that accounts for approximately 15% of all brain cancers (Source: American Cancer Society).
  • Research has shown that certain adult stem cells can selectively eradicate cancer stem cells, with a 95% efficacy rate in selective targeting (Source: Vitro Diagnostics, Inc.).

Sources:

  • Vitro Diagnostics, Inc.
  • Cancer Weekly editors
  • NewsRx.com